Get the Stockscreener App
4.85
1.68%
0.08
After Hours:
4.86
0.01
+0.21%
Nutriband Inc stock is traded at $4.85, with a volume of 14,494.
It is up +1.68% in the last 24 hours and down -15.51% over the past month.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
See More
Previous Close:
$4.77
Open:
$4.64
24h Volume:
14,494
Relative Volume:
0.47
Market Cap:
$54.93M
Revenue:
$2.09M
Net Income/Loss:
$-5.28M
P/E Ratio:
-8.2203
EPS:
-0.59
Net Cash Flow:
$-3.64M
1W Performance:
-2.61%
1M Performance:
-15.51%
6M Performance:
-4.90%
1Y Performance:
+78.31%
1-Day Range:
$4.64
$4.975
1-Week Range:
$4.62
$5.14
52-Week Range:
$2.22
$9.595
Nutriband Inc Stock (NTRB) Company Profile
Name
Nutriband Inc
Sector
Industry
Phone
407 377-6695
Address
121 S. ORANGE AVE., ORLANDO
Compare NTRB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NTRB
Nutriband Inc
|
4.85 | 54.93M | 2.09M | -5.28M | -3.64M | -0.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
464.56 | 119.70B | 10.63B | -479.80M | -1.35B | 13.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
754.87 | 82.75B | 13.85B | 4.65B | 3.32B | 35.06 |
|
ARGX
Argen X Se Adr
|
614.59 | 36.73B | 1.86B | -40.29M | -1.28B | -4.16 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
253.74 | 32.53B | 2.09B | -332.26M | 16.06M | -4.14 |
|
BNTX
Biontech Se Adr
|
120.72 | 28.50B | 3.30B | -501.07M | 1.03B | 11.54 |
Nutriband Inc Stock (NTRB) Latest News
Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology - The Manila Times
Nutriband Secures Hong Kong Patent for Abuse-Deterrent Patch Technology, Eyes $200M Market | NTRB Stock News - StockTitan
(NTRB) Technical Pivots with Risk Controls - Stock Traders Daily
Nutriband (NASDAQ:NTRB) Receives Full Patent Approval for AVERSA™ Abuse and Misuse Deterrent Transdermal SystemORLANDO, FL / ACCESSWIRE / October 31, 2024 / Nutriband (NASDAQ:NTRB) has recently disclosed that the Chinese National Intel - Defense World
Nutriband Secures Chinese Patent for AVERSA™ Technology - TipRanks
Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application - AccessWire
(NTRB) Technical Data - Stock Traders Daily
Nutriband (NASDAQ:NTRB) Stock Price Down 8.1%Time to Sell? - MarketBeat
Nutriband (NASDAQ:NTRB) Stock Price Down 8.1% – Here’s What Happened - Defense World
(NTRB) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Nutriband receives Costa Rica MoH approval for Mosquito Repellent Patch - TipRanks
Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica - AccessWire
Objective long/short (NTRB) Report - Stock Traders Daily
Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17 - AccessWire
Analyzing Sanara MedTech (NASDAQ:SMTI) and Nutriband (NASDAQ:NTRB) - Defense World
Nutriband (NASDAQ:NTRBW) Trading 6.5% Higher - Defense World
Nutriband (NASDAQ:NTRB) Trading 0.7% Higher - MarketBeat
Nutriband (NASDAQ:NTRB) Trading Up 0.7% - Defense World
(NTRB) Trading Signals - Stock Traders Daily
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Announces Receipt of Notice of Allowance for China Patent Application Covering AVERSA(TM) Technology - MSN
Head to Head Review: Nutriband (NASDAQ:NTRB) and Jin Medical International (NASDAQ:ZJYL) - Defense World
Nutriband secures patent in China for abuse-deterrent patch - Investing.com
Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology - AccessWire
Nutriband Inc (NTRB-Q) QuotePress Release - The Globe and Mail
Nutriband (NASDAQ: NTRB) Inks Licensing Agreement to Use Bitrex(R) for Flagship Product - Barchart
The 5 Public Companies Leading the Fight Against Fentanyl — Plus 10 Facts You Should Know - InvestorNews Inc.
Nutriband inks deal to enhance opioid patch safety - Investing.com
Nutriband inks deal to enhance opioid patch safety By Investing.com - Investing.com Canada
Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead ProductAversa(TM) Fentanyl Transdermal Patch - AccessWire
Bubble Tea Craze Hits Par Market with New Ninja Bubble Tea Shop - Cornish Stuff
Keith Martell Purchases 1,250 Shares of Nutrien Ltd. (TSE:NTR) Stock - MarketBeat
Nutrien Ltd (NTR) Stock: Uncovering 52-Week Market Trends - The InvestChronicle
NutriLab Joins NeoSpectra LabStore, Expanding Options for Quick On-Site Analysis of Feed and Feed Ingredients - AccessWire
Massachusetts Financial Services Co. MA Has $133.43 Million Stock Position in Nutrien Ltd. (NYSE:NTR) - MarketBeat
PATS previews: Key focus for Nutriment - Pet Business World News
Insider Buying: Nutrien Ltd. (TSE:NTR) Senior Officer Buys 300 Shares of Stock - Defense World
Nutriband Announces Stock Buyback and Advances in Fentanyl Patch Development - TipRanks
NTR’s Q2 earnings predictions: What the experts say - US Post News
Daiwa Securities Group Inc. Purchases Shares of 1,832 Nutrien Ltd. (NYSE:NTR) - Defense World
Nutrien wins NSC Safety Innovation Award and celebrates two semi-finalist achievements - Nutrien
Marriage’s launches new Nutri Pressed range - Pet Gazette
Houweling Americas announces exclusive partnership with Nutrien Solutions in British Columbia - hortidaily.com
No Frills Grocery to take over former Nesters Market at Gordon and Bernard - Castanet.net
Is ProstaLite the Natural Solution for Prostate Support? A Comprehensive Review - Islands' Sounder
How To Balance A Tech Job & Cricket? Learn The Saurabh Netravalkar Way- WATCH - Times Now
Nutriband to repurchase $1 million in common stock - Investing.com India
Shoppers can’t get over with this NutriBullet kitchen essential on sale for under $100 - LADbible
Nutriband to repurchase $1 million in common stock By Investing.com - Investing.com Canada
Nutricare launches first aid products for pets - Inside FMCG
Microsoft, Intel And 3 Stocks To Watch Heading Into Tuesday - Benzinga
Nutrien Ltd. stock falls Monday, underperforms market - MarketWatch
Nutriband Inc Stock (NTRB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):